188040 — Bio Port Korea Income Statement
0.000.00%
Last trade - 00:00- KR₩62bn
- KR₩65bn
- KR₩73bn
- 69
- 74
- 16
- 54
Annual income statement for Bio Port Korea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Revenue | ||
| Total Revenue | 68,699 | 73,346 |
| Cost of Revenue | ||
| Gross Profit | 19,124 | 20,976 |
| Selling / General / Administrative Expenses | ||
| Research And Development | ||
| Depreciation and Amortization | ||
| Unusual Expense / Income | ||
| Total Operating Expenses | 63,780 | 69,473 |
| Operating Profit | 4,919 | 3,873 |
| Gain / Loss on Sale of Assets | ||
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | 3,595 | 5,352 |
| Provision for Income Taxes | ||
| Net Income After Taxes | 3,369 | 4,112 |
| Net Income Before Extraordinary Items | ||
| Net Income | 3,369 | 4,112 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Diluted Net Income | 3,369 | 4,112 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | 761 | 2,305 |